Miriam Melis, Ph.D.

2011- Dept. Biomedical Sciences University of Cagliari, Italy 
"Miriam Melis"
Mean distance: 14.27 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Frau R, Miczán V, Traccis F, et al. (2019) Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone. Nature Neuroscience
Cadoni C, De Felice M, Corongiu S, et al. (2019) Role of genetic background in the effects of adolescent nicotine exposure on mesolimbic dopamine transmission. Addiction Biology. e12803
Frau R, Fanni S, Serra V, et al. (2019) Dysfunctional mesocortical dopamine circuit at pre-adolescence is associated to aggressive behavior in MAO-A hypomorphic mice exposed to early life stress. Neuropharmacology
Godar SC, Mosher LJ, Scheggi S, et al. (2019) Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT receptor activation. Neuropharmacology
De Felice M, Melis M, Aroni S, et al. (2018) The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia. Cns Neuroscience & Therapeutics
Secci ME, Mascia P, Sagheddu C, et al. (2018) Astrocytic Mechanisms Involving Kynurenic Acid Control Δ-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas. Molecular Neurobiology
Porcu A, Melis M, Turecek R, et al. (2018) Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gαi/o protein inhibitor. Neuropharmacology. 133: 107-120
Sørensen AT, Ledri M, Melis M, et al. (2017) Altered Chloride Homeostasis Decreases the Action Potential Threshold and Increases Hyperexcitability in Hippocampal Neurons. Eneuro. 4
Diana M, Raij T, Melis M, et al. (2017) Rehabilitating the addicted brain with transcranial magnetic stimulation. Nature Reviews. Neuroscience
Puligheddu M, Melis M, Pillolla G, et al. (2017) Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy. Epilepsia
See more...